Drug used to treat ectopic pregnancy with low hCG levels?

NVS Staff Nurse - 2022

Obstetrics & Gynaecology

Easy

Appeared in: NVS Staff Nurse - 2022

Explanation

Single-dose Methotrexate is the standard first-line medical treatment for a hemodynamically stable patient with an unruptured ectopic pregnancy.
The success of this therapy is highest in patients with favorable prognostic indicators, most importantly a low initial serum β-hCG level (typically below 5,000 mIU/mL).
Methotrexate is a folic acid antagonist that works by inhibiting DNA synthesis in the rapidly dividing cells of the trophoblast, thereby resolving the ectopic pregnancy without surgery.
This approach offers simplicity, lower cost, and avoids the risks associated with surgery and anesthesia.

Option A: Surgery is a broad term for an invasive procedure. While surgery (specifically laparoscopy or laparotomy) is a treatment for ectopic pregnancy, it is not the first-line drug therapy, especially for stable patients with low hCG levels.
Option C: Laparoscopy is the preferred surgical method for treating ectopic pregnancy in stable patients, but it is not a drug. Medical management with methotrexate is the preferred first-line treatment when criteria are met.
Option D: A double-dose or multi-dose regimen of methotrexate is not the initial treatment for a patient with low hCG levels. It is a secondary option.

Clinical Relevance

Nursing practice connection: Knowing Medical management of ectopic pregnancy helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Nurses are critical in monitoring patients receiving methotrexate for signs of treatment failure or tubal rupture (e.g., worsening abdominal pain, tachycardia, hypotension), which constitutes a medical emergency requiring immediate surgical intervention.
Patient education is a key nursing responsibility. This includes explaining the side effects of methotrexate, the importance of avoiding substances that interfere with it (folic acid, alcohol, NSAIDs), and the necessity of strict adherence to follow-up β-hCG testing.
What if the patient presented with severe abdominal pain, dizziness, and a blood pressure of 80/50 mmHg? In that case, the patient is hemodynamically unstable, likely from a ruptured ectopic pregnancy. The priority would be immediate fluid resuscitation and emergency surgery (laparotomy), not methotrexate therapy.

How to Approach the Question

First, identify the clinical condition presented in the question, which is an ectopic pregnancy.
Next, identify the key qualifying information: the patient has 'low hCG levels'. This is a critical factor in determining the appropriate management.
Recall the main treatment modalities for ectopic pregnancy: expectant management, medical management (methotrexate), and surgical management (laparoscopy or laparotomy).
Focus on the medical management options, as the question asks for a 'drug'. This narrows it down to the methotrexate options.
Differentiate between the single-dose and double-dose methotrexate regimens. Remember that the single-dose protocol is the standard first-line approach for stable patients with favorable criteria, especially low hCG levels.
Conclude that a single dose of methotrexate is the most appropriate initial drug treatment for this specific clinical scenario.

Concept Tested & Keywords

Concept Tested: Medical management of ectopic pregnancy
Stem keywords: ectopic pregnancy, low hCG levels, drug
Lead-in keywords: used to treat
Clinical cues: Low hCG levels: This is a key indicator for the success of single-dose methotrexate therapy.
Negative lead-in flag: false

QJsPHWEwt4LsQVHzgeU4aA

E6 Obstetrics Williams p. 22-41